Weiss Ratings Reiterates "Buy (B-)" Rating for National Health Investors (NYSE:NHI)

Key Points

• Weiss Ratings has reiterated a "Buy (B-)" rating for National Health Investors (NYSE:NHI), indicating confidence in the company’s stock performance.
• Analysts from multiple firms have increased their price targets for NHI, with Truist Financial and Wells Fargo raising their objectives to $81.00 and $80.00, respectively.
• NHI reported a quarterly earnings per share of $1.22, exceeding estimates while achieving a year-over-year revenue increase of 6.7%.

National Health Investors (NYSE:NHI - Get Free Report)'s stock had its "buy (b-)" rating reissued by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Other research analysts have also recently issued reports about the stock. Truist Financial boosted their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a report on Friday, August 15th. Wells Fargo & Company upped their price target on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a report on Wednesday, August 27th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a report on Wednesday, October 1st. Cantor Fitzgerald began coverage on shares of National Health Investors in a report on Wednesday, October 1st. They set an "overweight" rating and a $90.00 price target for the company. Finally, Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, National Health Investors has a consensus rating of "Buy" and an average price target of $84.83.

National Health Investors Trading Down 0.1%

Shares of NYSE NHI traded down $0.06 during midday trading on Wednesday, reaching $74.99. The company had a trading volume of 19,892 shares, compared to its average volume of 239,716. The stock has a market cap of $3.56 billion, a PE ratio of 23.96, a price-to-earnings-growth ratio of 3.26 and a beta of 0.77. National Health Investors has a one year low of $65.13 and a one year high of $82.32. The firm's fifty day moving average price is $76.94 and its 200-day moving average price is $74.12. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The firm had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. During the same quarter in the previous year, the company posted $1.18 earnings per share. The business's revenue was up 6.7% on a year-over-year basis. On average, equities research analysts anticipate that National Health Investors will post 4.41 earnings per share for the current year.

Institutional Trading of National Health Investors

Several hedge funds have recently added to or reduced their stakes in the business. Ausbil Investment Management Ltd grew its position in National Health Investors by 152.9% in the 3rd quarter. Ausbil Investment Management Ltd now owns 12,850 shares of the real estate investment trust's stock valued at $1,026,000 after buying an additional 7,769 shares in the last quarter. Caldwell Trust Co acquired a new position in shares of National Health Investors during the second quarter valued at approximately $122,000. Osaic Holdings Inc. raised its holdings in National Health Investors by 24.1% during the second quarter. Osaic Holdings Inc. now owns 1,629 shares of the real estate investment trust's stock worth $115,000 after purchasing an additional 316 shares in the last quarter. Thrivent Financial for Lutherans bought a new position in National Health Investors during the 2nd quarter valued at $975,000. Finally, CANADA LIFE ASSURANCE Co boosted its stake in National Health Investors by 11.9% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 83,636 shares of the real estate investment trust's stock valued at $5,870,000 after purchasing an additional 8,887 shares in the last quarter. Institutional investors own 62.51% of the company's stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.